Latest Biotech News

Several companies have reported advancements in cancer diagnostics and treatments. Saga Diagnostics achieved Medicare coverage for its Pathlight molecular residual disease test for breast cancer...

Recent advances in gene and cell therapies include FDA approvals and promising trial results. PTC Therapeutics obtained FDA approval for Sephience, an oral therapy for phenylketonuria, expanding...

Research teams have developed transformative technologies for environmental and agricultural applications. Carnegie Mellon University scientists employed AI-generated synthetic images to enhance...

The FDA has permitted Sarepta Therapeutics to resume shipments of its gene therapy Elevidys for ambulatory patients with Duchenne muscular dystrophy (DMD) following an investigation that concluded...

Novo Nordisk has substantially lowered its 2025 sales growth expectations for its obesity and diabetes treatment portfolio, including GLP-1 agonists Ozempic and Wegovy, citing increased...

Apellis Pharmaceuticals received FDA approval to broaden the labeling of its complement C3 inhibitor, Empaveli (pegcetacoplan), for treatment of complement 3 glomerulopathy (C3G) and primary...

Bristol Myers Squibb is divesting five immune-modulating drug candidates, including three already in clinical development, to a newly formed biotech company financed with $300 million led by Bain...

Facing declining revenue from blockbuster products like Keytruda and Gardasil, Merck announced an ambitious $3 billion annual cost-saving program to be completed by 2027. The initiative includes...

GeneDx, a genetic diagnostics company, announced a 49% year-over-year revenue increase in Q2 2025, totaling $102.7 million and marking its fourth consecutive profitable quarter. Growth is...

Researchers from Stanford University and the Chan Zuckerberg Biohub developed a novel AI-based ‘Virtual Lab,’ where multiple specialized AI agents collaborate, simulating multidisciplinary...

An interdisciplinary team from Stanford, Princeton, Google DeepMind, and UC Berkeley introduced CRISPR-GPT, an AI system combining large language models with expert knowledge to automate design...

Madrigal Pharmaceuticals entered an exclusive global licensing agreement with China-based CSPC Pharmaceutical Group for SYH-2086, a preclinical oral small-molecule GLP-1 receptor agonist. The deal...

Academic institutions like Roswell Park Comprehensive Cancer Center are significantly scaling in-house clinical-grade cell manufacturing facilities, enabling higher throughput and tighter...

The FDA has reversed its earlier halt on Sarepta Therapeutics’ gene therapy Elevidys for Duchenne muscular dystrophy, allowing shipments to ambulatory patients to resume after investigations found...

Merck announced a $3 billion annual cost reduction plan by 2027 to redirect investments into newly launched and pipeline drugs across oncology and cardiometabolic areas ahead of upcoming...

Novo Nordisk appointed Mike Doustdar as its new CEO amid lowered financial guidance for 2025, cutting expected sales growth of blockbuster obesity and diabetes drugs Wegovy and Ozempic to 8–14%...

Breakthroughs in AI-powered research environments and gene editing automation are transforming life sciences. The Virtual Lab platform utilizes AI agents specialized in scientific roles to conduct...

Digitization in cell and gene therapy (CGT) manufacturing is increasing traceability and efficiency but also raising cybersecurity risks, highlighting the sector’s emerging critical infrastructure...

Strategic partnerships and capital raises marked the biopharma landscape, with Bristol Myers Squibb spinning off five autoimmune assets into a new company supported by $300 million from Bain...

Novel diagnostic improvements and therapy candidates continue to surface. Apellis Pharmaceuticals gained FDA approval expanding Empaveli's use to two rare kidney diseases, complement 3...